Skip to main content
University College London logo

University College London

University · London

Quantum biomedicine is UCL's flagship national role: it leads Q-BIOMED, the hub building quantum sensors for earlier diagnosis of cancer, heart disease and Alzheimer's, with Cambridge, Oxford, Warwick, Cardiff and Heriot-Watt. John Morton, who directs the UCL Quantum Science and Technology Institute, is the hub's principal investigator, and in May 2026 it gained £902,000 from EPSRC's Accelerating Capability Fund to bring in new collaborators and map clinical needs with UCLPartners. UCL researchers co-founded the algorithms company Phasecraft in 2019 with the University of Bristol, and Morton is also a founder of silicon qubit maker Quantum Motion.

University College London, in London, appears in six UK quantum projects listed here. In this directory it leads Q-BIOMED and is a partner in 5 more. People profiled here include John Morton (Co-Director and PI) and Toby Cubitt (Co-Founder).

Sources: Q-BIOMED: home · Q-BIOMED: our team · Q-BIOMED secures £902K to expand healthcare quantum sensing (Quantum Zeitgeist, May 2026) · UCL spinout developing quantum algorithms raises £13 million (UCL News)

Compare with others

Profile last checked 2 October 2026

Projects (6)

Leads (1)

  • Active Hub · 2024 onwards

    UK Quantum Biomedical Sensing Research Hub

    Q-BIOMED

    A national research hub that develops quantum sensors for earlier diagnosis of disease. UCL and the University of Cambridge lead it.

    Role: Lead

    Funding: £24m

    Themes: Sensing, Biomedical and health, Imaging

Partner in (5)

In the news

Recent articles from Quantum Zeitgeist that mention University College London.

All 7 articles mentioning University College London

Partnerships (6)

Research, commercial and investment relationships, by year. Partners with a profile here are linked.

Similar organisations

Chosen by shared specialisms, then location and type.

Company data from Entangled Future. News from Quantum Zeitgeist. Last checked 2 October 2026.

Logos and names are trademarks of their respective owners, used to identify them. No endorsement implied.